BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23027454)

  • 1. Sex and gender aspects in antiarrhythmic therapy.
    Kurokawa J; Kodama M; Furukawa T; Clancy CE
    Handb Exp Pharmacol; 2012; (214):237-63. PubMed ID: 23027454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-genomic action of sex steroid hormones and cardiac repolarization.
    Kurokawa J; Furukawa T
    Biol Pharm Bull; 2013; 36(1):8-12. PubMed ID: 23302631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex hormonal regulation of cardiac ion channels in drug-induced QT syndromes.
    Kurokawa J; Kodama M; Clancy CE; Furukawa T
    Pharmacol Ther; 2016 Dec; 168():23-28. PubMed ID: 27595633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome.
    Drici MD; Clément N
    Drug Saf; 2001; 24(8):575-85. PubMed ID: 11480490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy in inherited and acquired ventricular arrhythmia in structurally normal adult hearts.
    Ortmans S; Daval C; Aguilar M; Compagno P; Cadrin-Tourigny J; Dyrda K; Rivard L; Tadros R
    Expert Opin Pharmacother; 2019 Dec; 20(17):2101-2114. PubMed ID: 31566420
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulation of cardiac ion channels via non-genomic action of sex steroid hormones: implication for the gender difference in cardiac arrhythmias.
    Furukawa T; Kurokawa J
    Pharmacol Ther; 2007 Jul; 115(1):106-15. PubMed ID: 17583354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic arrhythmias and gender].
    Biernacka EK
    Przegl Lek; 2014; 71(3):139-41. PubMed ID: 25154209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multiscale computational modelling approach predicts mechanisms of female sex risk in the setting of arousal-induced arrhythmias.
    Yang PC; Perissinotti LL; López-Redondo F; Wang Y; DeMarco KR; Jeng MT; Vorobyov I; Harvey RD; Kurokawa J; Noskov SY; Clancy CE
    J Physiol; 2017 Jul; 595(14):4695-4723. PubMed ID: 28516454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of sex steroid hormones on susceptibility to cardiac arrhythmias: a simulation study.
    Yang PC; Kurokawa J; Furukawa T; Clancy CE
    PLoS Comput Biol; 2010 Jan; 6(1):e1000658. PubMed ID: 20126530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sex hormones on cardiac repolarization.
    Yang PC; Clancy CE
    J Cardiovasc Pharmacol; 2010 Aug; 56(2):123-9. PubMed ID: 20164789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex, hormones, and repolarization.
    Pham TV; Rosen MR
    Cardiovasc Res; 2002 Feb; 53(3):740-51. PubMed ID: 11861044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual Dimorphisms, Anti-Hormonal Therapy and Cardiac Arrhythmias.
    Grouthier V; Moey MYY; Gandjbakhch E; Waintraub X; Funck-Brentano C; Bachelot A; Salem JE
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Female gender as a risk factor for drug-induced cardiac arrhythmias: evaluation of clinical and experimental evidence.
    Ebert SN; Liu XK; Woosley RL
    J Womens Health; 1998 Jun; 7(5):547-57. PubMed ID: 9650155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender disparity in cardiac electrophysiology: implications for cardiac safety pharmacology.
    Jonsson MK; Vos MA; Duker G; Demolombe S; van Veen TA
    Pharmacol Ther; 2010 Jul; 127(1):9-18. PubMed ID: 20462510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs for men and women - how important is gender as a risk factor for TdP?
    Coker SJ
    Pharmacol Ther; 2008 Aug; 119(2):186-94. PubMed ID: 18472167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Torsade de pointes.
    Roden DM
    Clin Cardiol; 1993 Sep; 16(9):683-6. PubMed ID: 7902224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes.
    Abi-Gerges N; Philp K; Pollard C; Wakefield I; Hammond TG; Valentin JP
    Fundam Clin Pharmacol; 2004 Apr; 18(2):139-51. PubMed ID: 15066127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New data on the antiarrhythmic value of parenteral magnesium treatment: magnesium and ventricular arrhythmias.
    Perticone F; Ceravolo R; De Novara G; Torchia L; Cloro C
    Magnes Res; 1992 Dec; 5(4):265-72. PubMed ID: 1296762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proarrhythmic actions of antiarrhythmic drugs: a review.
    Campbell TJ
    Aust N Z J Med; 1990 Jun; 20(3):275-82. PubMed ID: 2196873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.